Citadel Advisors »

Jazz Pharmaceuticals shares owned by Citadel Advisors

Quarter-by-quarter ownership of Jazz Pharmaceuticals (JAZZ) shares owned by Citadel Advisors from 13F filings

Historical chart of Citadel Advisors investment in Jazz Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Jazz Pharmaceuticals held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Jazz Pharmaceuticals by Citadel Advisors

Quarter filed Position value Share count Share price at filing
2013-03-31 $12M 212k 55.91
2012-12-31 $19M 361k 53.20
2012-09-30 $28M 492k 57.01
2012-06-30 $528k 12k 45.03
2012-03-31 $14M 278k 48.47

More positions owned by Citadel Advisors

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
NVIDIA Corporation Call Option (NVDA)
Tesla Motors Call Option (TSLA)
Apple Call Option (AAPL)
Meta Platforms Cl A Call Option (META)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Amazon Call Option (AMZN)
Microstrategy Cl A New Call Option (MSTR)
Broadcom Call Option (AVGO)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Netflix Call Option (NFLX)
Advanced Micro Devices Call Option (AMD)
Booking Holdings Call Option (BKNG)

View all positions for Citadel Advisors

Top funds holding Jazz Pharmaceuticals

Vanguard Group
BlackRock
LSV Asset Management
Pacer Advisors
Dimensional Fund Advisors
State Street Corporation
Capital World Investors
Ameriprise Financial
EcoR1 Capital
Jpmorgan Chase & Co
Camber Capital Management
Geode Capital Management
Polaris Capital Management
Swedbank AB
Renaissance Technologies

View all funds holding Jazz Pharmaceuticals